Markets

Exane Asset Management Buys Monsanto Co, Biogen Inc, Qiagen NV, Sells Citigroup Inc, W R Grace, ...

Exane Asset Management

  • New Purchases: MON , BIIB , BAC , ALXN, OLN, NXPI, LBTYA, WOOF, MBLY, VWR,
  • Added Positions:QGEN, ASH, FTI, GILD, DB, BMY, PCAR, DBVT, SU, HAL,
  • Reduced Positions:C, UBS, WFC, TSU, APD, HES, TMUS, AXTA, APC, CLR,
  • Sold Out:GRA, WLK, SHPG, PPG, CF, ZBH, ILMN, CHTR, VIV, VSM,

For the details of Exane Asset Management's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Exane+Asset+Management

These are the top 5 holdings of Exane Asset Management

  1. Bristol-Myers Squibb Company ( BMY ) - 554,362 shares, 9.63% of the total portfolio. Shares added by 6.58%
  2. Gilead Sciences Inc ( GILD ) - 333,602 shares, 7.36% of the total portfolio. Shares added by 28.99%
  3. Monsanto Co ( MON ) - 199,510 shares, 7.36% of the total portfolio. New Position
  4. Air Products & Chemicals Inc ( APD ) - 152,629 shares, 6.81% of the total portfolio. Shares reduced by 23.69%
  5. Qiagen NV ( QGEN ) - 638,868 shares, 6.63% of the total portfolio. Shares added by 232.07%

New Purchase: Monsanto Co ( MON )

Exane Asset Management initiated holdings in Monsanto Co. The purchase prices were between $113.2 and $118.75, with an estimated average price of $116.61. The stock is now traded at around $116.67. The impact to the portfolio due to this purchase was 7.36%. The holdings were 199,510 shares as of 2017-06-30.

New Purchase: Biogen Inc (BIIB)

Exane Asset Management initiated holdings in Biogen Inc. The purchase prices were between $246.54 and $286.89, with an estimated average price of $264.46. The stock is now traded at around $282.60. The impact to the portfolio due to this purchase was 5.6%. The holdings were 66,122 shares as of 2017-06-30.

New Purchase: Bank of America Corporation (BAC)

Exane Asset Management initiated holdings in Bank of America Corporation. The purchase prices were between $22.23 and $24.32, with an estimated average price of $23.31. The stock is now traded at around $23.90. The impact to the portfolio due to this purchase was 3.78%. The holdings were 500,000 shares as of 2017-06-30.

New Purchase: Alexion Pharmaceuticals Inc (ALXN)

Exane Asset Management initiated holdings in Alexion Pharmaceuticals Inc. The purchase prices were between $97.7 and $133.41, with an estimated average price of $116.38. The stock is now traded at around $126.77. The impact to the portfolio due to this purchase was 3.52%. The holdings were 92,773 shares as of 2017-06-30.

New Purchase: Olin Corp (OLN)

Exane Asset Management initiated holdings in Olin Corp. The purchase prices were between $28.24 and $33.54, with an estimated average price of $30.65. The stock is now traded at around $30.56. The impact to the portfolio due to this purchase was 2.36%. The holdings were 250,053 shares as of 2017-06-30.

New Purchase: NXP Semiconductors NV (NXPI)

Exane Asset Management initiated holdings in NXP Semiconductors NV. The purchase prices were between $103.17 and $109.98, with an estimated average price of $107.01. The stock is now traded at around $109.46. The impact to the portfolio due to this purchase was 0.73%. The holdings were 21,400 shares as of 2017-06-30.

Added: Qiagen NV ( QGEN )

Exane Asset Management added to the holdings in Qiagen NV by 232.07%. The purchase prices were between $27.83 and $34.93, with an estimated average price of $31.78. The stock is now traded at around $34.06. The impact to the portfolio due to this purchase was 4.63%. The holdings were 638,868 shares as of 2017-06-30.

Added: Ashland Global Holdings Inc (ASH)

Exane Asset Management added to the holdings in Ashland Global Holdings Inc by 72.01%. The purchase prices were between $59.48 and $67.45, with an estimated average price of $63.45. The stock is now traded at around $66.39. The impact to the portfolio due to this purchase was 2.38%. The holdings were 276,715 shares as of 2017-06-30.

Added: TechnipFMC PLC (FTI)

Exane Asset Management added to the holdings in TechnipFMC PLC by 246.06%. The purchase prices were between $26.49 and $33.64, with an estimated average price of $30.39. The stock is now traded at around $27.81. The impact to the portfolio due to this purchase was 1.87%. The holdings were 311,191 shares as of 2017-06-30.

Added: Gilead Sciences Inc ( GILD )

Exane Asset Management added to the holdings in Gilead Sciences Inc by 28.99%. The purchase prices were between $64.12 and $71.92, with an estimated average price of $66.5. The stock is now traded at around $71.69. The impact to the portfolio due to this purchase was 1.65%. The holdings were 333,602 shares as of 2017-06-30.

Added: Deutsche Bank AG (DB)

Exane Asset Management added to the holdings in Deutsche Bank AG by 212.23%. The purchase prices were between $15.86 and $19.35, with an estimated average price of $17.68. The stock is now traded at around $18.50. The impact to the portfolio due to this purchase was 1.2%. The holdings were 319,821 shares as of 2017-06-30.

Added: PACCAR Inc (PCAR)

Exane Asset Management added to the holdings in PACCAR Inc by 32.81%. The purchase prices were between $62.32 and $68.06, with an estimated average price of $64.83. The stock is now traded at around $68.45. The impact to the portfolio due to this purchase was 0.37%. The holdings were 72,293 shares as of 2017-06-30.

Sold Out: W R Grace & Co (GRA)

Exane Asset Management sold out the holdings in W R Grace & Co. The sale prices were between $67.16 and $72.58, with an estimated average price of $70.09.

Sold Out: Westlake Chemical Corp (WLK)

Exane Asset Management sold out the holdings in Westlake Chemical Corp. The sale prices were between $60.09 and $67.34, with an estimated average price of $63.49.

Sold Out: Shire PLC (SHPG)

Exane Asset Management sold out the holdings in Shire PLC. The sale prices were between $162.35 and $190, with an estimated average price of $174.91.

Sold Out: PPG Industries Inc (PPG)

Exane Asset Management sold out the holdings in PPG Industries Inc. The sale prices were between $104.42 and $111.57, with an estimated average price of $108.12.

Sold Out: CF Industries Holdings Inc (CF)

Exane Asset Management sold out the holdings in CF Industries Holdings Inc. The sale prices were between $25.51 and $29.86, with an estimated average price of $27.57.

Sold Out: Zimmer Biomet Holdings Inc (ZBH)

Exane Asset Management sold out the holdings in Zimmer Biomet Holdings Inc. The sale prices were between $116.54 and $129.39, with an estimated average price of $122.02.

Reduced: Citigroup Inc (C)

Exane Asset Management reduced to the holdings in Citigroup Inc by 70.54%. The sale prices were between $57.72 and $66.98, with an estimated average price of $61.22. The stock is now traded at around $66.89. The impact to the portfolio due to this sale was -5.55%. Exane Asset Management still held 125,000 shares as of 2017-06-30.

Reduced: UBS Group AG (UBS)

Exane Asset Management reduced to the holdings in UBS Group AG by 72.45%. The sale prices were between $15.19 and $17.65, with an estimated average price of $16.24. The stock is now traded at around $17.65. The impact to the portfolio due to this sale was -3.27%. Exane Asset Management still held 250,000 shares as of 2017-06-30.

Reduced: Wells Fargo & Co (WFC)

Exane Asset Management reduced to the holdings in Wells Fargo & Co by 55.51%. The sale prices were between $51.14 and $55.78, with an estimated average price of $53.58. The stock is now traded at around $54.80. The impact to the portfolio due to this sale was -2.69%. Exane Asset Management still held 125,000 shares as of 2017-06-30.

Reduced: Tim Participacoes SA (TSU)

Exane Asset Management reduced to the holdings in Tim Participacoes SA by 27.73%. The sale prices were between $13.75 and $16.56, with an estimated average price of $15.45. The stock is now traded at around $16.01. The impact to the portfolio due to this sale was -2.45%. Exane Asset Management still held 1,286,336 shares as of 2017-06-30.

Premium Members

This article first appeared on GuruFocus .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

QGEN APD GILD BMY

Other Topics

Stocks